Prime Medicine (PRME) Short-term Investments (2021 - 2026)
Prime Medicine's Short-term Investments came in at $47.62 million for Q2 2026, down 0.7% from $47.95 million a year earlier and down 33.3% from the prior quarter.
Powered by 
Analysis
Prime Medicine (PRME) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Prime Medicine's Short-term Investments was $114.65 million.
- Short-term Investments carries a four-year compound annual growth rate of 13.9% (FY2021 to FY2025).
- Going back by year, Short-term Investments was $7.97 million in FY2024 (-90.1%), $80.09 million in FY2023 (-18.7%), $98.47 million in FY2022 (+44.3%) and $68.24 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Short-term Investments since Q4 2024.
- Year-over-year, Short-term Investments increased in two of the last seven quarters, with an average decline of 10.1%.
- The fastest year-over-year change in Short-term Investments over five years came in Q3 2025 (growth of 146.6%), and the weakest in Q4 2024 (a decline of 90.1%).
- Business Quant data shows PRME's Short-term Investments at $71.39 million (Q1 2026), $114.65 million (Q4 2025) and $141.89 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Prime Medicine | 656.62 Mn | 35.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.62 Mn |
| Mar 31, 2026 | 71.39 Mn |
| Dec 31, 2025 | 114.65 Mn |
| Sep 30, 2025 | 141.89 Mn |
| Jun 30, 2025 | 47.95 Mn |
| Mar 31, 2025 | 52.38 Mn |
| Dec 31, 2024 | 7.97 Mn |
| Sep 30, 2024 | 57.55 Mn |
| Jun 30, 2024 | 107.27 Mn |
| Mar 31, 2024 | 116.56 Mn |
| Dec 31, 2023 | 80.09 Mn |
| Sep 30, 2023 | 121.36 Mn |
| Jun 30, 2023 | 87.04 Mn |
| Mar 31, 2023 | 109.92 Mn |
| Dec 31, 2022 | 98.47 Mn |
| Sep 30, 2022 | 89.18 Mn |
| Dec 31, 2021 | 68.24 Mn |
API Access
Prime Medicine Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=PRME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "PRME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=PRME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();